Tag: LIMITED

EUROCASTLE INVESTMENT LIMITED

SINGAPORE, June 11, 2026 (GLOBE NEWSWIRE) -- ChowChow Cloud International Holdings Limited (“Chowchow”, the “Company”) (NYSE American: CHOW) announced today that the Company had become aware of unusual trading activity in its ordinary shares on the NYSE American LLC (the “NYSE American”) on June 8, 2026 and June 9, 2026. The Company is issuing this press release pursuant to Section 401(d) of the NYSE American Company Guide. The Company has made inquiries and has been unable to determine whether corrective actions are appropriate at this time. The Company is further announcing that there has been no material development in its business and affairs not previously disclosed or, to its knowledge, any other reason to account for the unusual market action.

CALGARY, Alberta, June 11, 2026 (GLOBE NEWSWIRE) -- Veteran Capital Corp. ("Veteran") (TSXV: VCC.P), a Capital Pool Company listed on the TSX Venture Exchange (the "Exchange"), announces that it has terminated its letter of intent with Powerhive, Inc. ("Powerhive") for its proposed Qualifying Transaction as a result of Powerhive’s failure to complete its required financing and/or enter into a binding definitive agreement within the timeframes set out in the letter of intent, despite repeated extensions.

LAS VEGAS, June 11, 2026 (GLOBE NEWSWIRE) -- HF Foods Group Inc. (NASDAQ: HFFG), a leading distributor of international foodservice solutions to Asian restaurants and other businesses across the United States, announces that its Board of Directors (the “Board”) has approved a limited duration stockholder rights plan (the “Rights Plan”) and declared a dividend distribution of one right (“Right”) for each outstanding share of the Company’s common stock to stockholders of record as of the close of business on June 22, 2026.

NEW YORK, June 11, 2026 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the results of the June 2026 quarterly rebalance of the Nasdaq-100 Index^® (NDX^®), which will become effective prior to market open on Monday, June 22, 2026.

— Sovleplenib demonstrated rapid and durable hemoglobin response with favorable safety profile —

DALLAS, June 11, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.^® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, announced today that it has entered into securities purchase agreements for the purchase and sale of 3,883,496 shares of its common stock (or pre-funded warrants in lieu thereof), Series A-1 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock and Series A-2 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock at a purchase price of $1.03 per share of common stock (or pre-funded warrant in lieu thereof) and associated preferred investment options in a private placement priced at-the-market under Nasdaq rules.